DEXCOM, INC. (DXCM) Return on equity 2016–2025
DEXCOM, INC. (DXCM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
30.5%FY2025 · since FY2016: -23.1% → 30.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 30.5% | +3.1 pp |
| FY2024 | 27.4% | +1.2 pp |
| FY2023 | 26.2% | +10.2 pp |
| FY2022 | 16.0% | +5.4 pp |
| FY2021 | 10.6% | -24.8 pp |
| FY2020 | 35.4% | +24.0 pp |
| FY2019 | 11.5% | +30.6 pp |
| FY2018 | -19.2% | -7.2 pp |
| FY2017 | -12.0% | +11.1 pp |
| FY2016 | -23.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice